Brad Scheckner was appointed Vice President of Field Sales & Operations at Omeza in August 2023. Brad brings more than two decades of experience across biopharmaceutical, diagnostic, and medical device companies, including field sales and leadership positions at Genzyme, Sanofi, Crescendo Bioscience, Flexion Therapeutics, and Electromedical Products International.
He possesses significant cross-functional expertise in strategic marketing, market and payer access, business analytics, and business development as well as extensive knowledge of target healthcare settings, from specialty practices and ambulatory surgical centers to Veterans Affairs Hospitals and the Department of Defense.
Throughout his career, he has built and led multiple first-line management and sales teams, overseeing four product launches across various disease states. Additionally, Brad has served in multiple leadership roles in which he has liaised with marketing, business analytics, and employee engagement teams to develop a cohesive strategic approach that aligns the organization with sales in the pursuit of common goals and objectives.
Brad is a graduate of Florida State University, where he earned his degree in Business Management.
